Exploring CEACAM5 as a Therapeutic Target
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) represents a significant cell surface glycoprotein demonstrating enhanced expression patterns within multiple adenocarcinoma types, notably colorectal, gastric, and non-small cell lung cancer (NSCLC) cases
